847O Sequential chemoradiotherapy versus induction chemotherapy plus concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicentre, open-label, non-inferiority, randomised, phase III trialChenxia Hu, Xiayun He, Fei Xue et al.|Annals of Oncology|2024Cited by 1
Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 StudyLisa Licitra, Song Qu, Ye Guo et al.|Journal of Clinical Oncology|2026Cited by 0